ArticleBMC gastroenterology2020

Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review.

Ulf Helwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.